Japan Morning Connection: AI and Tech Strength Cooling Ahead of Potential Govt Shutdown and EoQ
Memory names took a leg lower, setting a poor tone for JP peers. Medtech names took a hit with potential tarriffs and price capping pressures.
388 Views
Kitazato IPO Trading - Demand Was Strong
Kitazato (368A JP) manufactures and sells medical devices and products for fertility treatment. It raised around US$130m in its Japan IPO. In this...
393 Views
APAC Healthcare Weekly (June 15)- CSPC, Wuxi Bio, Samsung Bio, Daiichi Sankyo, SanBio, Cochlear
CSPC entered research collaboration with AstraZeneca. Wuxi Bio is constructing new plant in China. Samsung Bio signed new CDMO contract. Daiichi...
494 Views
Kitazato IPO - Isn’t Particularly Enticing Apart from the Dividend Yield
Kitazato (368A JP) manufactures and sells medical devices and products for fertility treatment. It aims to raise around US$130m in its Japan IPO.
466 Views
BIG Nippon Electric Glass (5214) Buyback, Possibly Offset by Cross-Holder Selling
Nippon Electric Glass is rebuilding this year, hopes to be better over the next 5yrs. They now target 8% ROE, 2% DOE, and expect to spend ÂĄ50bn on...
540 Views